FormFactor, Inc. (FORM) 10-K Summary
Business Context and Reporting Period
Company: FormFactor, Inc.
Filing Type: Annual Report on Form 10-K
Reporting Period: Fiscal year ended December 27, 2025 (52 weeks)
Business Overview: A leading provider of electrical and optical test and measurement technologies for the semiconductor lifecycle. The company operates two segments: Probe Cards (customized probe cards and analytical probes) and Systems (probe stations, thermal, and cryogenic systems). Key growth drivers include High-Bandwidth Memory (HBM) for AI infrastructure and silicon photonics.
Key Financial Metrics
| Metric (in thousands) | Fiscal 2025 | Fiscal 2024 | Fiscal 2023 |
|---|---|---|---|
| Total Revenue | $784,993 | $763,599 | $663,102 |
| Gross Profit | $308,851 | $307,923 | $258,580 |
| Gross Margin | 39.3% | 40.3% | 39.0% |
| Operating Income | $57,070 | $64,780 | $82,756 |
| Net Income | $54,361 | $69,614 | $82,387 |
| Diluted EPS | $0.69 | $0.89 | $1.05 |
| Operating Cash Flow | $115,398 | $117,534 | $64,602 |
| Cash & Marketable Securities | $275,172 | $360,023 | N/A |
| Total Debt (Term Loan) | $12,258 | $13,368 | N/A |
Note: Fiscal 2024 and 2023 results included significant one-time gains from business divestitures ($20.6M and $73.0M respectively), which were absent in 2025.
Material Changes vs. Prior Period
- Revenue Growth: Record annual revenue of $785.0 million, up 2.8% from 2024. Growth was driven by the DRAM market (specifically HBM for AI) and the Systems segment.
- Profitability Decline: Net income decreased 22% year-over-year. This was primarily due to the absence of the $20.6 million gain on the sale of China operations recognized in 2024.
- Margin Pressure: Gross margin declined to 39.3% from 40.3%. This was attributed to higher manufacturing costs, including a 1.4% impact from tariffs, and a shift in product mix toward lower-margin DRAM products, partially offset by favorable factory utilization.
- Geographic Shift: Revenue from South Korea increased to 30.3% (from 24.2%) due to HBM demand. Revenue from China decreased to 7.4% (from 13.5%) due to export restrictions.
- Segment Performance: Probe Cards revenue grew 1.9% to $637.9M. Systems revenue grew 6.9% to $147.1M.
Guidance, Outlook, and Risks
- Restructuring: In January 2026, the company announced a restructuring plan to consolidate manufacturing facilities in Carlsbad and Baldwin Park, California. This is expected to result in charges of $30 million to $40 million in fiscal 2026, primarily for leasehold impairments and severance.
- Capital Expenditures: The company is ramping a new manufacturing facility in Farmers Branch, Texas, with expected production starting late in fiscal 2026. Estimated capital expenditures for this ramp are $140 million to $170 million.
- Acquisitions & Investments: Acquired Keystone Photonics (December 2025) to strengthen silicon photonics capabilities. Acquired a 20% equity interest in FICT Limited (February 2025).
- Tax Law Changes: The "One Big Beautiful Bill Act" (OBBBA) signed in July 2025 repealed the capitalization of R&D expenditures and reduced deductions on foreign-derived income, resulting in a modest increase in the effective tax rate to 18.7%.
- Key Risks:
- Customer Concentration: SK hynix represented 22.9% of total revenue in 2025. Two customers accounted for 33.5% of revenue in 2024.
- Geopolitics: Ongoing U.S.-China trade tensions and export controls continue to impact revenue from Chinese customers.
- Inventory: Custom nature of probe cards creates risk of inventory obsolescence if customer demand forecasts are inaccurate.
Investor Verification Checklist
- Restructuring Impact: Verify the timing and cash impact of the $30M-$40M restructuring charges announced for fiscal 2026.
- HBM Demand Sustainability: Assess the durability of the HBM-driven revenue growth in the DRAM segment given the cyclical nature of the semiconductor industry.
- Texas Facility Ramp: Monitor the progress of the Farmers Branch, Texas facility build-out and its ability to meet the projected late-2026 production start without cost overruns.
- Tax Rate Normalization: Confirm the long-term effective tax rate post-OBBBA implementation and the realization of deferred tax assets.
- Customer Diversification: Evaluate progress in reducing reliance on SK hynix (22.9% of revenue) and mitigating risks associated with China export restrictions.